Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 16 min ago
Peer-reviewedCC BY-NC-ND 4.0BMC Microbiology

Global genomic surveillance and temporal trends of carbapenemase-encoding β-lactamase genes in Klebsiella pneumoniae using NCBI pathogen detection data

  1. 1Biological Sciences Education Department, University of Skills Training and Entrepreneurial Development, Ashanti Mampong, Ghana

Abstract

The global spread of carbapenem-resistant Klebsiella pneumoniae is weakening the effectiveness of last-resort antibiotics and making severe infections increasingly difficult to treat. This study examined the geographical distribution, temporal patterns and co-occurrence of carbapenemase genes among K. pneumoniae genome assemblies deposited in the National Center for Biotechnology Information Pathogen Detection database. Genome metadata and antimicrobial resistance genotype information were retrieved between January and February 2026. After data cleaning, 67,057 unique genome assemblies from 123 countries contributed 77,975 carbapenemase-gene detections. Gene frequencies were summarised by continent, country, year and sample source. Poisson and negative binomial regression models were used to examine temporal patterns from 2013 to 2025. Genome-level co-occurrence was assessed using phi correlation coefficients, Jaccard similarity, odds ratios and Fisher’s exact tests. blaKPC was the most frequently detected gene, with 39,832 detections (51.08%), followed by blaNDM with 24,412 (31.31%). blaNDM was the dominant gene in Africa, accounting for 1,101 detections (52.68%), whereas blaKPC was dominant in the Americas, Asia, Europe and Oceania, accounting for 59.29%, 56.50%, 38.37% and 38.77% of detections, respectively. Urine and blood were the main sample sources, representing approximately 30% and 22% of the analysed genomes, respectively. Yearly trend analysis showed increases in blaNDM, blaOXA-232 and blaOXA-181. The strongest negative association was found between blaKPC and blaNDM (φ = −0.69), although genomes carrying either gene frequently contained additional antimicrobial resistance genes. These findings demonstrate clear geographical and temporal differences in carbapenemase genes among genome assemblies deposited in NCBI pathogen detection. However, differences in sequencing capacity and database submissions across countries and years should be considered when interpreting the findings. Continued genomic surveillance, antimicrobial stewardship and stronger infection prevention and control measures are needed, particularly in underrepresented regions.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12866-026-05502-w.

Related

  1. Rapid inter-regional and cross-border dissemination of carbapenemase-producing Klebsiella pneumoniae ST6668, European Union, April 2022 to August 2026.
    Giulia Errico, Marius Linkevicius, Alessandra Lo Sciuto +33
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletinPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Association of Carbapenemase Gene Profiles with Ceftazidime–avibactam Resistance in Carbapenem-Resistant Klebsiella pneumoniae
    Elif Tuğçe Güner, Ayfer Bakır, Cemal Çiçek +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General medicineCrossref
  3. Genomic analysis and antimicrobial resistance profiling of Klebsiella pneumoniae clinical isolates from urinary tract infections in India: prevalence of class A β-lactamase with molecular docking and simulation insights.
    Liyana Nk, Tusar Mondal, Tobika R +4
    Access microbiologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Sequence type-associated carbapenemase genes in sewage-derived Klebsiella pneumoniae and characterization of a tigecycline-resistant ST34 strain
    Jundong Zhu, Min Fu, Li Xiang +4
    npj Antimicrobials and ResistancePeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseasePMC
  5. Beyond Resistance: Carbapenemase Gene Profiles and Mortality in ICU Patients with Carbapenem-Resistant Klebsiella pneumoniae Infections
    Esra Kaya, Elif Okumuş, Elif Gülsüm Torun
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
BibTeX
@article{ofori2026global,
  title = {{Global genomic surveillance and temporal trends of carbapenemase-encoding β-lactamase genes in Klebsiella pneumoniae using NCBI pathogen detection data}},
  author = {Samuel Ayetibo Ofori},
  journal = {BMC Microbiology},
  year = {2026},
  month = aug,
  doi = {10.1186/s12866-026-05502-w},
  url = {https://doi.org/10.1186/s12866-026-05502-w},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Global genomic surveillance and temporal trends of carbapenemase-encoding β-lactamase genes in Klebsiella pneumoniae using NCBI pathogen detection data
AU  - Samuel Ayetibo Ofori
PY  - 2026
DA  - 2026/08/10
JO  - BMC Microbiology
DO  - 10.1186/s12866-026-05502-w
UR  - https://doi.org/10.1186/s12866-026-05502-w
AB  - The global spread of carbapenem-resistant Klebsiella pneumoniae is weakening the effectiveness of last-resort antibiotics and making severe infections increasingly difficult to treat. This study examined the geographical distribution, temporal patterns and co-occurrence of carbapenemase genes among K. pneumoniae genome assemblies deposited in the National Center for Biotechnology Information Pathogen Detection database. Genome metadata and antimicrobial resistance genotype information were retrieved between January and February 2026. After data cleaning, 67,057 unique genome assemblies from 123 countries contributed 77,975 carbapenemase-gene detections. Gene frequencies were summarised by continent, country, year and sample source. Poisson and negative binomial regression models were used to examine temporal patterns from 2013 to 2025. Genome-level co-occurrence was assessed using phi correlation coefficients, Jaccard similarity, odds ratios and Fisher’s exact tests. blaKPC was the most frequently detected gene, with 39,832 detections (51.08%), followed by blaNDM with 24,412 (31.31%). blaNDM was the dominant gene in Africa, accounting for 1,101 detections (52.68%), whereas blaKPC was dominant in the Americas, Asia, Europe and Oceania, accounting for 59.29%, 56.50%, 38.37% and 38.77% of detections, respectively. Urine and blood were the main sample sources, representing approximately 30% and 22% of the analysed genomes, respectively. Yearly trend analysis showed increases in blaNDM, blaOXA-232 and blaOXA-181. The strongest negative association was found between blaKPC and blaNDM (φ = −0.69), although genomes carrying either gene frequently contained additional antimicrobial resistance genes. These findings demonstrate clear geographical and temporal differences in carbapenemase genes among genome assemblies deposited in NCBI pathogen detection. However, differences in sequencing capacity and database submissions across countries and years should be considered when interpreting the findings. Continued genomic surveillance, antimicrobial stewardship and stronger infection prevention and control measures are needed, particularly in underrepresented regions.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12866-026-05502-w.
SN  - 1471-2180
ER  -